Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti ☰
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Colera

Bibliografia

Quali fonti bibliografiche considerare per il Colera?

Le informazioni contenute nella ricerca Pharmamedix dedicata al colera sono state analizzate con riferimento alle seguenti fonti.

  1. Alavi S. et al., Cell, 2020, 181 (7), 1533.
  2. Ali M. et al., PLoS Negl. Trop. Dis., 2015, 9 (6), e0003832.
  3. Arifuzzaman M. et al., PLoS Negl. Trop. Dis., 2011, 5 (12), e1413.
  4. Asadgol Z. et al., Environ. Sci. Pollut. Res. Int., 2020, 27 (28), 34906.
  5. Baine W.B. et al., Lancet, 1974, 2 (7893), 1370.
  6. Bavishi C., Dupont H.L., Aliment. Pharmacol. Ther., 2011, 34 (11-12), 1269.
  7. Chowdhury F.et al., Clin. Microbiol. Rev., 2022, 35 (3), e0021121.
  8. Clemens J.D. et al., Lancet, 2017, 390 (10101), 1539.
  9. Cornell T.R., Kelly-Hope L.A., BMJ Glob. Health., 2025, 10 (9), e019626.
  10. Davis W. Et al., Curr. Epidemiol. Rep., 2018, 5 (3), 303.
  11. Deen J. et al., Vaccine, 2020, 38 Suppl 1, A31.
  12. Engku Abd Rahman E.N.S. et al., J. Infect. Public Health., 2024, 17 (11), 102558.
  13. Frank C. et al., Euro. Suveill., 2025, 30 (14), 2500234.
  14. Global Task Force on Cholera Control, 2024, https://www.gtfcc.org/our-work/tools-technical-guidance/? (accesso: ottobre 2026).
  15. Global Task Force on Cholera Control, Section 7: Case management in Treatment Facilities, 2024a https://www.choleraoutbreak.org/book-page/section-7-case-management-treatment-facilities.html? (accesso: ottobre 2026).
  16. Global Task Force on Cholera Control Epidemiology and Laboratory Working Groups, Lancet Infect. Dis., 2025, 25 (4), e202.
  17. Hamre H.J. et al., Syst. Rev., 2023, 12 (1), 191.
  18. Harris J.B. et al., Infect. Immun., 2005, 73 (11), 7422.
  19. Harris J.B. et al., Lancet, 2012, 379 (9835), 2466.
  20. Holmgren J., Trop. Med. Infect. Dis., 2021, 6 (2), 64.
  21. Im J. et al., Open Forum Infect. Dis., 2024, 11 (1), ofad701.
  22. Jones N. et al., J. Water Health, 2020, 18 (2), 145.
  23. Kanungo S. et al., Lancet, 2022, 399 (10333), 1429.
  24. Komiazyk M. et al., Pol. J. Microbiol., 2014, 63 (1), 3.
  25. Leary B., Med. Ges. Gesch., 1997, 16, 125.
  26. Leibovici-Weissman Y. et al., Cochrane Database Syst. Rev., 2014, 2014 (6), CD008625.
  27. Maggi P. et al., Eur. J. Epidemiol., 1997, 13 (1), 95.
  28. Markina O.V. et al., Zh. Mikrobiol. Epidmiol. Immunobiol., 2013, (1), 9.
  29. Marumure J., M.A. Nyila, J. Trop. Med., 2024, 2024, 1981991.
  30. Masci Walter, Omeopatia - Tradizione e attualità, 2003, Tecniche Nuove.
  31. Mazzilli S. et al., Euro. Surveill., 2024, 29 (35), 2400518.
  32. Michell A.R., J.R. Soc. Med., 2016, 109 (12), 436.
  33. Montero D.A. et al., Front. Med. (Lausanne), 2023, 10, 1155751.
  34. Muhammad A.Y. et al., AIMS Microbiol., 2023, 9 (2), 346.
  35. Nateghizad H. et al., Front. Pharmacol., 2023, 14, 1027277.
  36. Nguyen T.T. et al., BMC Infect. Dis., 2025, 25 (1), 1165.
  37. Ricaboni D, et al., Travel. Med. Infect. Dis., 2019, 29, 60.
  38. Russini V. et al., Trop. Med. Infect. Dis., 2023, 8 (5), 266.
  39. Saif-Ur-Rahman K.M. et al., Cochrane Database Syst. Rev., 2024, 1 (1), CD014573.
  40. Sánchez E. et al., Appl. Environ. Microbiol., 2010, 76 (20), 6888.
  41. Seguiti C. et al., Case Rep. Infect. Dis., 2026, 2026, 5552486.
  42. Shackleton D. et al., Rev. Environ. Health, 2023, 39 (2), 313.
  43. Temre Y. Et al., BMJ Glob. Health., 2026, 11 (1), e020187.
  44. U.S. Centers for Disease Control and Prevention - CDC, Cholera – Cholera Clinical Detection, 2024, 13 August https://www.cdc.gov/cholera/php/laboratories/cholera-clinical-detection.html (accesso: ottobre 2026).
  45. U.S. Centers for Disease Control and Prevention - CDC, CDC Yellow Book - Cholera, 2025 https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/cholera.html (accesso: ottobre 2026).
  46. U.S. Centers for Disease Control and Prevention - CDC, Cholera – Preventing Cholera in Families, 2025a https://www.cdc.gov/cholera/prevention/about-how-family-members-can-prevent-infection.html (accesso: ottobre 2026).
  47. U.S. Centers for Disease Control and Prevention - CDC, Choera – Treating Cholera, 2025b, https://www.cdc.gov/cholera/treatment/ (accesso ottobre 2026).
  48. Walton M.G. et al., Front. Microbiol., 2023, 14, 1178538.
  49. World Health Organisation - WHO, 1993, Research guidelines for evaluating the safety and efficacy of herbal medicines.
  50. World Health Organization – WHO, Evidence to recommendation and GRADE tables for cholera position paper, 2017 (accesso: ottobre 2026) https://cdn.who.int/media/docs/default-source/immunization/position_paper_documents/cholera/cholera-grade-evidence-recommendation-tables.pdf (accesso: ottobre 2026).
  51. World Health Organisation – WHO, Clinical tools for cholera treatment facilities, 2024, 11 Dicember https://www.who.int/publications/i/item/B09194 (accesso: ottobra 2026).
  52. World Health Organisation - WHO, Cholera, 2026, 29 September https://www.who.int/news-room/fact-sheets/detail/cholera (accesso: ottobre 2026).
  53. World Health Organisation - WHO, Cholera outbreaks, 2026a, 29 September, https://www.who.int/news-room/questions-and-answers/item/cholera-outbreaks (accesso: ottobre 2026).
  54. Xu H. et al., Lancet Glob. Health, 2025, 13 (7), e1203.
  55. Yao X. et al., Int. J. Infect. Dis., 2026, 170, 108917.
  56. Zhang Q. et al., Microorganisms, 2024, 12 (4), 818.

 

;